Abstract: Western-blot analysis was used to study the reaction of koala antisera, two specific polyclonal antibodies and one monoclonal antibody, with chlamydial antigens in koalas infected with Chlamydia psittaci. The koala sera recognized four C. psittaci surface antigens, corresponding to the major outer membrane protein (39.5 kDa), 31 kDa protein, 18 kDa protein and lipopolysaccharide. The $25-23 LPS specific monoclonal antibody inhibited chlamydial infection (55-67%) with both koala strains (type I and type II). Both koala antiserum and rabbit polyclonal antibodies against either type of chlamydia significantly reduced the number of infected cells resulting from type II infections at a dilution of 1 in 20. Rabbit antiserum against type II was effective in neutralizing infection by type II elementary bodies, but was less effective against type I infection. In addition, no koala antiserum was effective in neutralizing type I infection.
Introduction
Infection with chlamydia gives rise to both humoral and cell-mediated responses in humans and in a range of other species [1] [2] [3] [4] [5] . However, the role of the antibody response in chlamydial infection is poorly understood [6] . In guinea pigs antibodies were found to recognize the following epitopes: 39 kDa (MOMP), 61 kDa, 84 kDa proteins and lipopolysaccharide (LPS) [7] . Human sera recognized two antigens, 18 and 30 kDa [8] ; the former was present on several serovars (D, L2, J and K) of C. trachomatis [9] . MOMP [10] and LPS (located on the outer membrane) were conserved structures common to all chlamydiae [11] . Antibodies to LPS were detected in serum from animals infected with chlamydia [7] and it was suggested that LPS may be an important virulence determinant [12] . Previously, the only genus-specific antigen recognized for Chlamydia 22 spp. was LPS [11] ; however, recent evidence has shown that other epitopes (proteins) have a genus-reactive determinant antigen [12] .
The ability of C. trachomatis biovars (trachoma and LGV) to infect cultured cells was neutralized by the presence of polyclonal antibodies against intact organisms, and monoclonal antibodies against particular antigens [13] [14] [15] [16] [17] . Polyclonal antibodies raised against elementary bodies (EBs) prevented attachment and ingestion of the LGV biovar in HeLa cells [8, 18] , and C. psittaci 6BC strain in L cells [19] . Monoclonal antibodies against epitopes in variable domains 1 and 4 of the MOMP gene were shown to block the attachment of C. trachomatis LGV and trachoma biovars to HeLa cells [17, 20] . Despite considerable examination of the diseases affecting koalas, the immune response to their predominant pathogen, C. psittaci, is poorly understood [21] . Disease is no longer considered the most significant danger to the overall survival of the koala in the wild in Australia; however, chlamydiosis appears to be a significant factor in the local decline of the species in some regions. Currently there is no preventative therapy for captive or wild koalas suffering from, or exposed to, a range of chlamydial diseases. Chlamydial disease was considered a contributing factor to koala population decline [22] and is currently the subject of concerted research aimed at diagnosis [23] , treatment [24] , and an understanding of the epidemiology of chlamydial infection [25] . Antibodies specific to both koala strains of C. psittaci were demonstrated to exist [26] ; however, the protective capability of these antibodies was not determined. During the current study we used Western-blot techniques and in vitro neutralization to investigate the immune response of koalas to C. psittaci antigens and elucidate the role of this response in protection against infection.
Materials and Methods

Study animals
Blood samples, urogenital and ocular swabs were collected as described by Weigler et al. [25] from 20 koalas from a range of locations within Queensland. Of these, three koalas appeared healthy, nine were suffering from bilateral conjunctivitis, six had 'dirty tail' (urogenital infection) and two had both bilateral conjunctivitis and 'dirty tail'. Serum was separated by centrifugation and stored at -80°C. The antisera used in this study were derived from rabbits immunized with chlamydial EBs (koala strains type I and type II derived from a BGM cell line) and koalas naturally infected with chlamydia.
Specimen analysis
For each koala sampled, four tests for chlamydial infection were employed.
Tissue culture. Tissue culture was carried out on swab material as described by Girjes et al. [27] .
Detection of koala anti-chlamydial antibodies.
Koala anti-chlamydial antibodies were detected in serum samples using the technique described by Girjes et al. [26] . Briefly, koala immunoglobulin (Ig), purified with a protein A Sepharose column, was used to derive rabbit anti-koala Ig serum in rabbits. The rabbit anti-koala Ig antiserum was used to detect the presence of antichlamydial antibodies in koala serum samples from which non-specific antibodies had been adsorbed with Escherichia coli and Streptococcus pyogenes antigens. The reaction was evaluated visually in the presence of goat anti-rabbit alkaline phosphatase conjugate substrates (Sigma). DNA probe. Exudate from ocular and urogenital swabs were blotted onto Hybond-N (Amersham) in a dot-blot apparatus (Bio-Rad). These Hybond membranes were placed on 3M filter paper (Whatman) saturated with denaturing solution (0.5 M NaOH, 1.5 M NaC1) for 8 min and transferred to neutralizing solution (1 M Tris-HC1, 1.5 M NaC1) for another 8 min. The membranes were dried and exposed to UV light for 2 min to fix the DNA, and probed with a chlamydial genus-specific probe, pKOC-10 [23] according to the method described by Maniatis et al. [28] .
Immuno-dot blot. A second membrane, prepared in the same manner as described for the DNA probe analysis was prepared for immunodot blot assay with rabbit anti-chlamydial antibodies [23] . Duplicate filters were made for each of the four tests.
Growth of chlamydia in Buffalo green monkey kidney (BGM) cell line
BGM cells (2 x 105 cells ml-1; Flow Laboratories) were grown in flat-bottomed polystyrene vials (5 ml, SCS 501 4H, Bunzl, Seaton, South Australia) containing 12 mm sterile cover-slips, and infected with dilutions of purified EBs to produce 100% infection. Four vials were used at each dilution. The cover-slips were recovered from representative cultures and stained with 5% (w/v) Giemsa in phosphate buffer (20 mM Na2HPO 4, 50 mM NaH2PO4.2H20, pH 6.5) for 1 h at room temperature. Inclusion forming units per ml were estimated as described by Furness et al. [29] .
Neutralization of chlamydial infection in vitro
Chlamydial EBs were isolated by centrifugation through a density gradient (Urografin-76 100 mg ml-1 sodium diatrizoate, 600 mg meglumine diatrizoate; Schering AG, Berlin, FRG). Chlamydial infection in tissue culture was neutralized with monoclonal antibody $25-23 (a gift from Dr. Helmut Brade, Forschunginstitut Borstel, Borstel, FRG) which recognizes the KDO trisaccharide region of LPS. For the in vitro neutralization assessment, polyclonal antibodies raised in rabbits against type I and type II heat-killed EBs were used. Sera from infected and uninfected koalas were examined in the protection study. For each type of test, several antibody dilutions were made in SPG buffer (220 mM sucrose, 7 mM potassium phosphate, 5 mM L-glutamic acid, pH 7.2). Aliquots (0.5 ml) of EB suspension containing 2 × 10 6 and 2 × 107 inclusion forming units (IFU) from koala strains type I and type II respectively were added to each vial containing 0.5 ml of antibody dilution. These vials were incubated in 5% CO 2 in air at 37°C for 1 h. Each isolate of infected material was used to inoculate four sets of coverslip BGM monolayers. EB suspensions, to which antibody had not been added, were used as a positive control under the same conditions. Inoculation conditions and fixation with methan-23 ol/acetic acid were carried out as described by Timms et al. [30] , except that incubation with the inoculum was sustained for 2 h and the coverslip was subsequently incubated in the presence of cycloheximide (1 p~g ml-~) for 2 h prior to staining. Antibody-mediated neutralization of chlamydial infection was assessed by counting the inclusion bodies formed (20 fields under light microscopy x400) by treated, as compared with untreated, EBs [29] .
SDS-PA GE electrophoresis
Purified chlamydial EBs were suspended in SDS buffer (2% (w/v) sodium dodecyl sulphate ((SDS), 10% (v/v) glycerol, 62.5 mM Tris-HC1, pH 6.8) and lysed in a boiling water bath for 10 rain [31] . Low and high molecular mass markers Numbers on the right hand side indicate the standard molecular mass marker (kDa). (BIO-RAD) were run at the same time as EBs lysate on SDS-PAGE gels (4.5% stacking gel, 12% separating gel), prepared as described by Laemmli [32] . Separated proteins were transferred onto nitrocellulose overnight (30 V, 40 mA) with a BIO-RAD Mini Trans-blot cell. Prestained standards were transferred simultaneously to assess transfer efficiency.
Imrnunoblotting assay
After transfer, the nitrocellulose membranes were pre-soaked for 1 h in blotting solution (10 mM Tris-HC1, 150 mM NaCl, 5% (w/v) skim milk powder, 0.5 ml l 1 Tween-20, pH 7.5) at room temperature. The membrane was incubated with shaking in blotting solution to which either rabbit anti-chlamydial antibodies (1 h, room temp.), monoclonal antibody (2 h, 37°C) or koala sera (1 h, room temp.) were added and was washed three times (10 min/wash) in blotting solution, or in the case of the monoclonal antibodies, washed four times with TBS/Tween-20 (50 mM Tris-HC1, 150 mM NaC1, 0.05% Tween-20, pH 7.4) containing 3% (w/v) skim milk pow-25 der. Rabbit anti-chlamydial antibodies were detected by adding goat anti-rabbit IgG alkaline phosphatase conjugate (Promega Biotec. Madison, WI) (1/2000 dilution, 50 mg ml l) in the presence of phosphatase substrates (nitro blue tetrazolium (50 mg ml-~) and 5-bromo-4-chloro-3-indolyl phosphate (50 mg ml L)). Koala antichlamydial antibodies were detected by the incorporation of a second incubation, with rabbit antikoala Ig antibodies [26] followed by three washes in blotting solution (10 min/wash) prior to detection. Monoclonal antibody $23-25 was detected following incubation with horseradish peroxidase (HRP) conjugate (Bio-Rad) (2 h, 37°C). The membrane was washed twice in TBS/Tween-20 and three times in TBS (10 min/wash) before incubation with HRP substrate (5 ml 4-chloro-1-napthol (30 mg ml 1) + 50 ml TBS + 30/zl H20 2) for 30 rain.
The $23-25 monoclonal antibody specific for the KDO-trisaccharide region of LPS was also used to confirm the expression of the common chlamydial epitope on the surface of E. coli.
Results
Protein patterns of C. psittaci koala strains
The SDS-PAGE analysis of the lysed EBs revealed some minor differences between the two koala chlamydial strains (Fig. 1) . Two visible bands at 29 and 26 kDa were seen only in type 2 strain. No differences were observed between batches of purified EBs from each koala strain.
Detection of chlamydial antigen by Western blotting
The $23-23 monoclonal antibody specific for the LPS epitope reacted with type I and type II as a sharp single band (Fig. 3A, lanes 1 and 2) . Two different epitopes were recognized by rabbit anti-chlamydia antibodies RAC1 and RAC2 (Table 1). For both chlamydial strains presented, increased binding was detected for these antibodies to LPS (migrating at the same position as that recognized by the LPS-specific monoclonal), compared to antigen corresponding in size to MOMP (Fig. 3A, lanes 3 and 4) , indicating variation in either binding affinity or antibody titre of the anti-LPS and anti-MOMP antibodies. The Western blot analysis using several koala sera detected three epitopes corresponding to 39.5 kDa, 31 kDa, 18 kDa as well as LPS. Antibodies recognizing LPS, MOMP and the 31 kDa proteins were found in two koala sera (Fig. 3A, lanes 5 and 6) . Two koala sera responded only to the LPS epitope (Fig. 3B) , another group of three koala sera only recognized MOMP (Fig. 3D) , three further sera reacted with both LPS and the 18 kDa protein (Fig. 3C) , four koala sera responded to the 31 kDa protein and LPS (Fig. 3C) and Western blotting failed to reveal the presence of antibodies to any epitopes in three koalas which were chlamydia-positive in gene probe and tissue culture. Sera from healthy koalas (gene probe, immuno-dot blot, tissue culture, and antibody screen [26] negative) and antiserum against the BGM cells (used to culture chlamydia) did not react with any chlamydial protein.
Neutralization of chlamydial infection in BGM cells
Compared with BGM cells infected with untreated EBs (positive control, Fig. 2D ) and uninfected BGM cells (negative control, Fig. 2A) , inhibition of more than 50% of inclusion bodies in vivo was recorded as positive neutralization. Anti-chlamydial antibodies produced by koalas caused a significant neutralization of chlamydial infection in vitro, especially against a type II koala chlamydial strain (Table 1) , with a considerable reduction in visible inclusion bodies (Fig.  2C) . Conversely, neither healthy koala serum nor rabbit anti-BGM antisera conferred protection, with almost 100% infection occurring (Fig. 2B) , similar to the untreated control. Although the polyclonal antibodies raised in rabbits against a type I strain were equally effective in neutralizing in vitro infectivity with either chlamydial type, polyclonal antibodies similarly raised against a type II strain, while effective against a type II strain, were less effective against the type I strain. By comparison, a monoclonal antibody raised against the KDO trisaccharide region of LPS (genus-specific epitope) had a protective effect against both type I and type II strains.
Titres of anti-chlamydial antibodies
Whereas, at high dilutions (1:100), none of the sera neutralized viable EBs, infection was inhibited by three of the sera tested at 1:10 dilution (Table 2) . Rabbit polyclonal antibodies raised against type II strain inhibited infection at 1:50 dilution, but did not inhibit type I strain infection. Similarly, at 1:20 dilution, rabbit antiserum (RAC1) and the $23-25 monoclonal antibody neutralized the type II strain infection, but were not effective against type I strain infection at greater than 1:10 dilution (Table 2) . Koala polyclonal antibodies and RACll rabbit polyclonal antibodies remained effective against type II strain at 1:50 dilution, but koala polyclonal antibodies did not effect neutralization at any dilution against type I strain.
Discussion
Various studies demonstrated that antisera, against either EBs or secretions from chlamydiainfected tissues, neutralized chlamydial infection [13, 20, 33] . Previously antibody directed against the 31 kDa and 18 kDa proteins inhibited chlamydial infection to the same extent as antibody raised against the whole organism [8] . Conversely, Levitt and Barol [34] reported that specific antibodies only provided short-term protection in vivo against chlamydia, not altering the occurrence of chronic infection or re-infection in populations at high risk of infection.
The data presented here demonstrate that koala antisera are similarly capable of reducing the infection of monolayer cultures by the C.
psittaci koala type II strain. Protection against type II strain varied between sera from infected koalas; however type I strain was unaffected by the presence of the sera. While cross-reactivity between the two strains of koala C. psittaci might be expected, it is not surprising that serum from infected animals failed to counter type I strain infection. Previously these two strains could be differentiated with a number of gene probes [27] and now by polymerase chain reaction (PCR) with specific primers [35] . The report of Hugall [35] suggests it is rare for both strains to be found in the same swab material. Peterson et al. [20] described differences in the susceptibilities of different biovars of C. trachomatis to neutralization by immune sera, reporting the relative resistance of the L2 serovar compared to the E serovar to be inoculum dependent. The results presented here do not suggest such a dependence to exist for the koala strains over a five-fold dilution range (Table 2) . A study of the inactivation of C.
trachomatis by normal human serum [36] reported no correlation between the anti-chlamydial activity of serum and the level of detectable anti-chlamydial antibody to exist. This was probably due to the fact that their assay depended on the complement-fixation (CF) titre, which would only detect anti-LPS antibodies.
Differences in the neutralizing capability of the polyclonal as compared to the monoclonal antibody are probably attributable to the different action of the two antibodies. Polyclonal antibodies were described as interacting with chlamydial MOMP, inhibiting inclusion formation by C.
trachomatis without affecting the attachment of EBs to the host cell membrane [14] , whereas monoclonal antibodies, specific to contiguous epitopes in MOMP, neutralized infectivity by inhibiting chlamydial attachment [37] . Conversely, Peeling et al. [39] suggested that intact IgG on the surface of chlamydiae could promote phagolysosomal fusion, by inhibiting essential nutritional needs such as ATP uptake, or preventing the developmental cycle in an unknown manner.
Immunoblotting has detected several chlamy- [7, 8, 10, 31, 39] . Characterization of antigens by Western blotting during this study revealed the immune response to chlamydial infection in koalas was directed against several antigens, including MOMP, 31 kDa and 18 kDa and LPS. The absense of antibody against LPS in six koala sera may be related to the release of LPS in the blood, reacting with specific anti-LPS antibody to form an immune complex [40] . Alternatively these animals may have a very poor response to LPS after a lengthy period of infection. Caldwell et al. [41] suggested that differences in the methods used to detect anti-LPS antibody may account for some of the reported variation in the recognition of LPS. The predominance of epitopes such as genus-specific LPS [11] and MOMP [10] were shown by enzyme immunoassay to be limited to periods immediately following the onset of overt clinical disease. The four antigens (MOMP, 31 kDa, 18 kDa and LPS) characterized during this study may be relevant to antibody-mediated protection in koalas; the identification of the specific antigen responsible for triggering the koala's initial antibody response is therefore a high priority for further study.
